Douglas Pharmaceuticals, founded in 1967, is a privately owned pharmaceutical and healthcare company based in Auckland, New Zealand, with a global footprint. It employs hundreds of staff and works with innovative partners to research, develop, manufacture, market and distribute prescription and consumer health products in over 50 countries worldwide. The company’s operations encompass high-quality pharmaceutical production under strict Good Manufacturing Practice (GMP) standards and a range of contract development and manufacturing services through Douglas CDMO. Its portfolio spans multiple therapeutic areas, and its products are formulated to meet the regulatory requirements of international markets.

Key products and services:

• Prescription pharmaceutical products in various therapeutic areas, including oncology, dermatology, the central nervous system and immunity.
• Contract development and manufacturing services (CDMO) for pharmaceutical and biotechnology companies, offering integrated drug development, formulation and commercial supply solutions.
• Manufacturing of specialised dosage forms such as softgels, liquids and other formulations compliant with global GMP standards.
• Research and development activities, including co-development and in-licensing partnerships for new and repurposed medicines.
• Production and distribution of over-the-counter healthcare and nutraceutical products.

Douglas Pharmaceuticals combines long-standing scientific expertise with global contract manufacturing capabilities to support both its own branded products and the development programmes of its partners. With decades of experience and a commitment to quality and regulatory compliance, the company aims to improve patient outcomes internationally while maintaining its reputation for service, innovation and operational excellence.